apixaban,enoxaparin
bms,pfizer
['freedom-covid', 'cardio']
dr. on freedom-covid shares, based on these findings, the use of therapeutic-dose anticoagulation may improve outcomes in non-critically ill patients hospitalized w/ covid who are at increased risk for adverse events but don't require icu care. #acc23/#wccardio 
The latest news from the American College of Cardiology (ACC) and the 🌎 of cardiovascular health. Follow @ACCinTouch for other ACC updates.